These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 29743994)

  • 1. Approaches to Left Atrial Appendage Closure: Device Design, Performance, and Limitations.
    Dave AS; Valderrábano M
    Methodist Debakey Cardiovasc J; 2017; 13(3):106-113. PubMed ID: 29743994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial appendage closure.
    Lin AC; Knight BP
    Prog Cardiovasc Dis; 2015; 58(2):195-201. PubMed ID: 26241302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.
    Price MJ; Reddy VY; Valderrábano M; Halperin JL; Gibson DN; Gordon N; Huber KC; Holmes DR
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1925-1932. PubMed ID: 26627989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous left atrial appendage occlusion: New perspectives for the method.
    Gorczyca-Michta I; Wożakowska-Kapłon B
    Cardiol J; 2017; 24(5):554-562. PubMed ID: 28281734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous Left Atrial Appendage Ligation for Stroke Prevention in Atrial Fibrillation.
    Valderrábano M; Price MJ
    Methodist Debakey Cardiovasc J; 2015; 11(2):94-9. PubMed ID: 26306126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial appendage closure: A therapy uniquely suited for specific populations of patients with atrial fibrillation.
    Black-Maier E; Piccini JP; Granger CB
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2968-2976. PubMed ID: 31520437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Atrial Appendage Occlusion for Stroke Prevention.
    Chanda A; Reilly JP
    Prog Cardiovasc Dis; 2017; 59(6):626-635. PubMed ID: 28457791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of current and emerging devices for percutaneous left atrial appendage closure.
    Chow DHF; Wong YH; Park JW; Lam YY; De Potter T; Rodés-Cabau J; Asmarats L; Sandri M; Sideris E; McCaw T; Lee RJ; Sievert H; Søndergaard L; De Backer O
    Trends Cardiovasc Med; 2019 May; 29(4):228-236. PubMed ID: 30205924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Left Atrial Appendage Closure: Current Devices and Clinical Outcomes.
    Asmarats L; Rodés-Cabau J
    Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical closure devices for atrial fibrillation.
    Price MJ; Holmes DR
    Trends Cardiovasc Med; 2014 Aug; 24(6):225-31. PubMed ID: 25066488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-surgical left atrial appendage closure for stroke prevention in atrial fibrillation.
    Friedman PA; Holmes DR
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1184-91. PubMed ID: 21914028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Bajwa RJ; Kovell L; Resar JR; Arbab-Zadeh A; Mandal K; Calkins H; Berger RD
    Clin Cardiol; 2017 Oct; 40(10):825-831. PubMed ID: 28750152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial appendage occlusion with the WATCHMAN™ for stroke prevention in atrial fibrillation.
    Price MJ
    Rev Cardiovasc Med; 2014; 15(2):142-51. PubMed ID: 25051131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation.
    Ussia GP; Mulè M; Cammalleri V; Scarabelli M; Barbanti M; Immè S; Mangiafico S; Marchese A; Galassi AR; Tamburino C
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):217-22. PubMed ID: 19472361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial experience of percutaneous left atrial appendage closure using the LAmbre device for thromboembolic prevention.
    Reinsch N; Ruprecht U; Buchholz J; Edel C; Kälsch H; Neven K
    J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):491-496. PubMed ID: 29894355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.